Actinic Keratosis Treatment Market Report, Strategies, Demand and Trend by Forecast to 2030
Actinic keratosis, simply put, is a scaly, rough patch on the skin which results from years of sun exposure. It is commonly found on the neck, scalp, forearms, back of the hands, ears, lips, or face. The size varies from a small inch to about a diameter, and when left untreated, such areas of the skin can turn into a serious type of skin cancer. Change in the color of the skin (brown, flesh-colored, or pink), hard wart-like surface, burning sensation and itching, and rough, patchy, scaly skin are some of its common symptoms.
The Actinic
Keratosis Treatment Market trends is anticipated to reach USD 3,548 Million
by 2030 at 6.2% CAGR during the forecast period 2022-2030. No two cases will
appear the same, yet is likely to share similar features such as sandpaper
texture, crusty patches, raised patches, and red scales. Though anyone can
develop actinic keratosis, but those with fair skin, particularly blonde or red
hair, green or blue eyes, or skin that easily burns or freckles have a higher
risk of experiencing actinic keratosis.
Various factors are propelling the porokeratosis
treatments growth. These factors, according to the new MRFR report, include its
increasing prevalence, increasing acceptance of therapeutic procedures that are
minimally invasive, growing geriatric population, and the presence of suitable
medical coverage. Additional factors pushing market growth include the
availability of suitable medical attention and environmental factors such as
excessive sun exposure and ozone depletion.
Key Players
Leading players profiled in the actinic
keratosis treatment market report include Cipher Pharmaceuticals Inc., Valeant
Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Alma Lasers, Stanford
Chemicals, 3M, Leo Pharma, BioLineRx, and Biofrontera AG. Various strategies
have been adopted by key players to create a foothold in the market such as
research and development activities, joint ventures/partnership, mergers and
acquisitions, collaborations, expansions, product launches, and
development.
Market Segmentation
The MRFR report provides a complete
segmental analysis of the actinic keratosis treatment market report on the
basis of end user, procedure, and medication.
Based on medication, the actinic keratosis
treatment market is segmented into diclofenac gel, ingenol mebutate gel,
imiquimod cream, fluorouracil cream, and others.
Based on procedure, the actinic keratosis
treatment market is segmented into chemical peels, laser, photodynamic therapy,
cryotherapy, and others. Of these, the cryotherapy segment will have the
largest share in the market over the forecast period. This is a common
treatment used for actinic keratosis.
Based on end user, the actinic keratosis
treatment is segmented into ambulatory surgical centers, dermatology clinics,
and hospitals and oncology centers. Of these, the hospitals and oncology
segment will dominate the market over the forecast period.
Regional Analysis
By region, the actinic
keratosis treatment market report covers the latest trends and growth
opportunities across the Asia Pacific, Europe, the Americas, and the Middle
East and Africa. Of these, the Americas will spearhead the market over the
forecast period. Factors aiding growth in the region include easy availability
of advanced treatment methods such as monotherapy and combination therapy and
increasing efforts taken on cancer research in the region.
The actinic keratosis treatment market in
the APAC region is predicted to have significant growth over the forecast
period. Factors aiding growth in the region include growing government support
for medical tourism, rising healthcare spending, rising literacy rates, rapidly
growing healthcare infrastructure, and rising disposable income. India, Japan,
and China are the key contributors in this region.
The actinic keratosis treatment market in
Europe will have a favorable growth over the forecast period while the Middle
East and Africa will experience sluggish growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Comments
Post a Comment